GRI

1.1200.00%
DL

David L. Szekeres

Independent Chairman of the Board

Mr. David L. Szekeres JD, is CEO & Director of Smart Home Protection LLC. Mr. Szekeres is Chairman of the Board of CureMatch, Inc. Mr. Szekeres was Director of CureMatch, Inc. Mr. David is President of Connect Biopharma Holdings Limited since June 12, 2024. He serves as Independent Chairman of the Board at GRI Bio, Inc. from April 2023 and serves as its Member Board of Directors in April 2023. He serves as Member of Executive Advisory Board at Colossal Biosciences Inc. Mr. Szekeres serves on Sanford Burnham Prebys’ Board of Directors. He also served on the Board of Directors of Edico Genome Inc. until its acquisition by Illumina in 2018 and Patara Pharma until its acquisition by Roivant Sciences in 2018. He joined Heron Therapeutics, Inc. as Chief Operating Officer and Head of Finance. He was Executive Vice President and Chief Operating Officer at Heron Therapeutics, Inc. since October 13, 2020 until July 20, 2023. Mr. Szekeres was Chief Legal, Business and Administrative Officer at Heron Therapeutics, Inc. since December 2019 until October 13, 2020 and was its General Counsel, Business Development and Corporate Secretary since March 17, 2016. Mr. Szekeres served as Senior Vice President of Heron Therapeutics, Inc. since 2016 until October 13, 2020. Mr. Szekeres served as the Chief Business Officer, General Counsel and Secretary at Regulus Therapeutics Inc. from February 2014 to December 3, 2015 and served as its Principal Financial & Accounting Officer since 2014 until December 3, 2015. In that role, Mr. Szekeres played a critical role in overseeing the company’s business, financial and legal responsibilities as it developed into a clinical stage corporation. Mr. Szekeres has legal and financial experience, primarily in the biotechnology industry. He joined Regulus in February 2014 and Heron in 2016. Prior to joining Regulus, from 2008 to 2014, Mr. Szekeres served as Head of Mergers and Acquisitions, Governance and Securities and Assistant Corporate Secretary at Life Technologies Corporation. He was Deputy General Counsel and Chief M&A Counsel at Life Technologies Corporation. At Life Technologies, he led more than fifty transactions, including leading the acquisition of Ion Torrent to expand Life's genomics business. He was also responsible for all legal functions in the areas of corporate transactions, corporate governance, SEC reporting and compliance. Prior to his time at Life, Mr. Szekeres held positions of increasing responsibility at a number of prestigious law firms, including Latham & Watkins LLP, Oâ Melveny & Myers LLP and Dechert LLP. From 2001 to 2006, Mr. Szekeres was Corporate Attorney at a number of law firms, including O’Melveny & Myers LLP and Latham & Watkins LLP. Prior to 2001, Mr. Szekeres served as Senior Associate in Investment Banking at investment bank Robertson Stephens, where he began his career in the investment banking group. He serves as Executive Chairman of Annai Systems Inc. He has been a Director of Annai Systems Inc. since February 2014. He serves as a Member of the Board of Directors of Anochi BioPharma and the San Diego chapter of the Association of Corporate Counsel. Mr. Szekeres holds a B.A. in criminology, law and society from the University of California at Irvine and a J.D. from Duke University School of Law.

Positions